The Norplant experience at the University Hospital of the West Indies

Journal of Obstetrics and Gynaecology

Volumn 17, Issue 6, 1997, Pages 569-572

  Rattray, Carole ^a   Robinson, C ^a   Hussey, E ^a   Macleod, Y ^a   Fagan, T ^a   Wynter, H H ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; LEVONORGESTREL;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BODY WEIGHT; CARIBBEAN ISLANDS; CLINICAL TRIAL; CONTRACEPTION; FAMILY PLANNING; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MENORRHAGIA; MENSTRUAL IRREGULARITY; NORMAL HUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0031448953     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443619768632     Document Type: Article

References (22)

1. Abdulla K. A., Elwan S. I., Salem H. S. and Shaaban M. M. (1985) Effect of early postpartum use of the contraceptive implants, Norplant, on the serum levels of immunoglobulins of the mothers and their breastfed infants. Contraception, 32, 261-266.
2. Affandi B., Lubis F., Prihartono J., Sutedi H. and Suyono H. (1987) Introduction of Norplant into a family planning programme: Indonesian experience. 12 pp. Unpublished.
3. Bardin C. W. and Sivin I. (1985) Norplant contraceptive implants: a new contraceptive for women. IPPF Medical Bulletin, 19, 2-4.
4. Croxatto H. B., Diaz S., Robertson D. N. and Pavez M. (1983) Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD. Contraception, 27, 281-288.
5. Croxatto H. B., Diaz S., Pavez M., Cardenas H., Larsson M. and Johansson E. D. B. (1988) Clearance of levonorgestrel from the circulation following removal of Norplant subdermal implants. Contraception, 38, 509-523.
6. Diaz S., Herreros C., Juez G., Casado M. E., Salvatierra A. M., Miranda P., Peralta O. and Croxatto H. B. (1985) Fertility regulation in nursing women: 7. Influence of Norplant levonorgestrel upon lactation and infant growth. Contraception, 32, 53-74.
7. Haiba N., El-Sahwi M. S. and Toppozada M. (1984) Metabolic changes during Norplant use. In: The Norplant Subdermal Contraceptive System, edited by M. M. Shaaban, pp. 107-114. Assiut, Egypt, Assiut University.
8. Holma P. and Robertson D. N. (1985) Cholesterol and HDL-cholesterol values in women during use of subdermal implants releasing levonorgestrel. Contraception, 32, 163-171.
9. Shikary Z. K., Betrabett S. S., Toddywala W. S., Patel D. M., Datey S. and Saxena B. N. (1986) Pharmacodynamic effects of levonorgestrel administered either orally or subdermally to early postpartum lactating mothers on the urinary levels of follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) in their breast-fed male infants. Contraception, 34, 403-412.
10. Kelly S. (1987) Inserting and removing Norplant implants. (Robert Wood Johnson School of Medicine). Personal communication.
11. Kurunmaki H. (1983) Contraception with levonorgestrel-releasing subdermal capsules, Norplant, after pregnancy termination. Contraception, 27, 473-482.
12. Lubis F., Prihartono J., Agoestina T., Affandi B. and Sutedi H. (1983) One-year experience with Norplant implants in Indonesia. Studies in Family Planning, 14, 181-184.
13. Population Council (1986b) Acceptors describe what they like, dislike, want to know about Norplant method. Norplant Worldwide, 4, p. 3.
14. Population Council (1986a) Norplant fact sheet. Norplant Worldwide, 5, pp. 2-4.
15. Population Council (1983) Norplant Contraceptive Implants: Instructions for Clinicians. New York, population Council. 17 pp.
16. Roy S., Mishell D. R., Jr, Robertson D. N., Krauss R. M., Lacarra M. and Duda M. J. (1984) Long term reversible contraception with levonorgestel-releasing Silastic rods. American Journal of Obstetrics and Gynaecology, 148, 1006-1013.
17. Satayapan S., Kanchanasinith K. and Varakamin S. (1983) Perceptions and acceptability of Norplant implants in Thailand. Studies in Family Planning, 14, 170-176.
18. Shaaban M. M., Elwan S. I., Abdalla S. A. and Darwish H. A. (1984a) Effect of subdermal levonorgestrel contraceptive implants, Norplant, on serum lipids. Contraception, 30, 413-419.
19. Shaaban M. M., Elwan S. I., El-Sharkawy M. M. and Farghaly A. S. (1984b) Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions. Contraception, 30, 407-412.
20. Sivin I., Sanchez F. A., Diaz S., Holma P., Coutinho E., McDonald O., Robertson D. N. and Stern J. (1983) Three-year experience with Norplant subdermal contraception. Fertility and Sterility, 39, 799-808.
21. World Health Organisation. Special programme of research, development and research training in human reproduction (1985) Facts about an implantable contraceptive: memorandum for a WHO meeting. Bulletin of the World Health Organisation, 63, 485-494.
22. Zimmerman M. (1985) Notes for a talk on Norplant acceptability at the Norplant User Perspective Meeting. New York, Population Council.